Seegene received CE IVDR marking for its Allplex MDRO Assay, a multiplex real-time PCR test for multidrug-resistant organisms tied to healthcare-associated infections. The company said the kit enables first-line screening before culture results are available and has launched it in Europe, with a stated plan to broaden antimicrobial resistance testing including an upcoming MRSA assay target for 2027.